ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,35049
0,00%
Bitcoin
66.466,18
0,41%
Brent Oil
82,275
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Rain Oncology Inc (RAIN)

  7. Rain Oncology Inc (RAIN) Notícias

RAIN

Rain Oncology (RAIN)

Rain Oncology Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RAIN
DataHoraFonteTítuloCódigoCompanhia
05/02/202408:41Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:RAINRain Oncology Inc
31/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RAINRain Oncology Inc
26/01/202418:58Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:RAINRain Oncology Inc
26/01/202418:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAINRain Oncology Inc
26/01/202418:32Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:RAINRain Oncology Inc
26/01/202411:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAINRain Oncology Inc
26/01/202411:19Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:RAINRain Oncology Inc
26/01/202411:13Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:RAINRain Oncology Inc
03/01/202416:57PR Newswire (US)Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law FirmNASDAQ:RAINRain Oncology Inc
27/12/202311:27Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:RAINRain Oncology Inc
27/12/202311:20Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:RAINRain Oncology Inc
14/12/202308:06Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:RAINRain Oncology Inc
09/11/202318:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RAINRain Oncology Inc
12/09/202306:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
11/08/202306:45PR Newswire (US)RAIN SHAREHOLDER ALERT: Jakubowitz Law Reminds Rain Shareholders of a Lead Plaintiff Deadline of September 12, 2023NASDAQ:RAINRain Oncology Inc
06/07/202306:45PR Newswire (US)INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: RAIN)NASDAQ:RAINRain Oncology Inc
30/06/202306:45PR Newswire (US)RAIN FRAUD ALERT: Jakubowitz Law is Investigating Rain Oncology Inc. in Connection with Potential Violations of Federal Securities LawsNASDAQ:RAINRain Oncology Inc
10/03/202319:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RAINRain Oncology Inc
09/03/202318:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RAINRain Oncology Inc
03/03/202319:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RAINRain Oncology Inc
14/02/202319:22Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RAINRain Oncology Inc
14/02/202317:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RAINRain Oncology Inc
18/11/202214:35TipRanksJonesTrading Reaffirms Their Buy Rating on Rain Therapeutics (RAIN)NASDAQ:RAINRain Oncology Inc
11/11/202213:25TipRanksJonesTrading Keeps Their Buy Rating on Rain Therapeutics (RAIN)NASDAQ:RAINRain Oncology Inc
10/11/202218:52Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RAINRain Oncology Inc
10/11/202218:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RAINRain Oncology Inc
04/11/202209:00GlobeNewswire Inc.Rain Therapeutics Announces $50 Million Registered Offering of Common StockNASDAQ:RAINRain Oncology Inc
04/11/202207:07Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:RAINRain Oncology Inc
20/09/202209:25TipRanksH.C. Wainwright Sticks to Their Buy Rating for Rain Therapeutics (RAIN)NASDAQ:RAINRain Oncology Inc
12/09/202209:15TipRanksRain Therapeutics (RAIN) Gets a Buy from JonesTradingNASDAQ:RAINRain Oncology Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:RAIN

Seu Histórico Recente

OKEX
ONTUSDT
Ontology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados